Cristina L. Cotarelo

Mannheim, BW 68167, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Prediction of Mutations and Outcome in Gastrointestinal Stromal Tumors with Deep Learning: A Multicenter, Multinational Study.

Journal: medRxiv : the preprint server for health sciences

Published: February 12, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors.

Journal: Cancer research

Published: January 12, 2026

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Journal: Cancer research

Published: January 12, 2026

Comparative Analysis of Histomorphological Quality and Quantitative Cell Assessment in Formalin-Fixed Paraffin-Embedded and Fresh Frozen Porcine Skin Biopsies.

Comparative Analysis of Histomorphological Quality and Quantitative Cell Assessment in Formalin-Fixed Paraffin-Embedded and Fresh Frozen Porcine Skin Biopsies.

Journal: Biomedicines

Published: January 10, 2026

Digital pathology platforms with integrated AI algorithms: a structured landscape analysis and recommendations for clinical implementation.

Digital pathology platforms with integrated AI algorithms: a structured landscape analysis and recommendations for clinical implementation.

Journal: Virchows Archiv : an international journal of pathology

Published: December 16, 2025

Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board.

Clinical benefit of additional whole-exome sequencing over panel sequencing in an all-comer real-world molecular tumor board.

Journal: ESMO open

Published: July 08, 2025

Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma.

Combining molecular patterns and clinical data for better immune checkpoint inhibitor prediction in metastatic urothelial carcinoma.

Journal: Cancer immunology, immunotherapy : CII

Published: June 16, 2025

Nestin as a Marker Beyond Angiogenesis-Expression Pattern in Haemangiomas and Lymphangiomas.

Nestin as a Marker Beyond Angiogenesis-Expression Pattern in Haemangiomas and Lymphangiomas.

Journal: Biomedicines

Published: January 10, 2025

Nuclei Detection and Segmentation of Histopathological Images Using a Feature Pyramidal Network Variant of a Mask R-CNN.

Nuclei Detection and Segmentation of Histopathological Images Using a Feature Pyramidal Network Variant of a Mask R-CNN.

Journal: Bioengineering (Basel, Switzerland)

Published: July 26, 2024

Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters.

Bicenter validation of a risk model for the preoperative prediction of extraprostatic extension of localized prostate cancer combining clinical and multiparametric MRI parameters.

Journal: World journal of urology

Published: February 22, 2024

Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases.

Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases.

Journal: Cancers

Published: February 22, 2023

Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2- Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2- Breast Cancer.

Functional Characterization of Circulating Tumor Cells (CTCs) from Metastatic ER+/HER2- Breast Cancer Reveals Dependence on HER2 and FOXM1 for Endocrine Therapy Resistance and Tumor Cell Survival: Implications for Treatment of ER+/HER2- Breast Cancer.

Journal: Cancers

Published: April 01, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026